Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach

Publisher： Karger

E-ISSN： 1421-9891|20|5|218-225

ISSN： 1022-6877

Source： European Addiction Research, Vol.20, Iss.5, 2014-04, pp. : 218-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulatory Issues Concerning the Development and Circulation of Nicotine-Containing Products: A Qualitative Study

By Rooke Catriona  

Nicotine & Tobacco Research, Vol. 15, Iss. 6, 2013-06 ,pp. : 1052-1059

Oxford University Press

Access to resources Recommend Favorite

Who's afraid of incompatible plasma? A balanced approach to the safe transfusion of blood products containing ABO‐incompatible plasma

By  

TRANSFUSION, Vol. 58, Iss. 2, 2018-02 ,pp. : 532-538

John Wiley & Sons Inc

Access to resources Recommend Favorite

Australian urban Indigenous smokers' perspectives on nicotine products and tobacco harm reduction

By  

DRUG AND ALCOHOL REVIEW, Vol. 37, Iss. 1, 2018-01 ,pp. : 87-96

John Wiley & Sons Inc

Access to resources Recommend Favorite

Estimating the accuracy of psychological scales using longitudinal data

By Rutter C.M.  

Biostatistics, Vol. 4, Iss. 1, 2003-01 ,pp. : 97-107

Oxford University Press

Access to resources Recommend Favorite

Estimating disease progression using panel data

By Mandel Micha  

Biostatistics, Vol. 11, Iss. 2, 2010-04 ,pp. : 304-316

Oxford University Press

Access to resources Recommend Favorite